Vital Signs: Hepatitis C Treatment Among Insured Adults — United States, 2019–2020

INTRODUCTION: Over 2 million adults in the United States have hepatitis C virus (HCV) infection, and it contributes to approximately 14,000 deaths a year. Eight to 12 weeks of highly effective direct-acting antiviral (DAA) treatment, which can cure ≥95% of cases, is recommended for persons with hepa...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, William W., Symum, Hasan, Sandul, Amy, Gupta, Neil, Patel, Priti, Nelson, Noele, Mermin, Jonathan, Wester, Carolyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Vital Signs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400534/
https://www.ncbi.nlm.nih.gov/pubmed/35951484
http://dx.doi.org/10.15585/mmwr.mm7132e1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400534/
https://www.ncbi.nlm.nih.gov/pubmed/35951484
http://dx.doi.org/10.15585/mmwr.mm7132e1

Ejemplares similares